Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
429 | 16394 | 35.3 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
220 | 3 | CYTOMEGALOVIRUS//VIROLOGY//JOURNAL OF VIROLOGY | 50388 |
429 | 2 | CYTOMEGALOVIRUS//HUMAN CYTOMEGALOVIRUS//HUMAN HERPESVIRUS 6 | 16394 |
405 | 1 | CYTOMEGALOVIRUS//VALGANCICLOVIR//PREEMPTIVE THERAPY | 3527 |
786 | 1 | HUMAN CYTOMEGALOVIRUS//HCMV//VIROLOGY | 3076 |
4155 | 1 | CONGENITAL INFECTION//CYTOMEGALOVIRUS//CONGENITAL CYTOMEGALOVIRUS INFECTION | 1836 |
4478 | 1 | HUMAN HERPESVIRUS 6//HHV 6//HUMAN HERPESVIRUS 7 | 1778 |
5022 | 1 | GUINEA PIG CYTOMEGALOVIRUS//CYTOMEGALOVIRUS//MURINE CYTOMEGALOVIRUS | 1686 |
5259 | 1 | CYTOMEGALOVIRUS RETINITIS//CMV RETINITIS//RETINITIS | 1649 |
13148 | 1 | CYTOMEGALOVIRUS//CYTOMEGALOVIRUS COLITIS//IMMUNOCOMPETENT | 857 |
15771 | 1 | UL97//GANCICLOVIR RESISTANCE//MARIBAVIR | 692 |
18635 | 1 | CMV PREVENTION//TRANSFUSION ASSOCIATED INFECTION//ACUTE EBV INFECTION VZV SPECIFIC IGA | 542 |
19136 | 1 | CYTOMEGALOVIRUS//INFECTION BARRIER//RAT HEART ENDOTHELIAL CELL LINES | 520 |
27372 | 1 | US28//STEALTH VIRUS//ACE PIGMENTS | 231 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYTOMEGALOVIRUS | authKW | 2722225 | 15% | 59% | 2501 |
2 | HUMAN CYTOMEGALOVIRUS | authKW | 677134 | 3% | 69% | 525 |
3 | HUMAN HERPESVIRUS 6 | authKW | 446200 | 2% | 71% | 339 |
4 | GANCICLOVIR | authKW | 414202 | 3% | 48% | 464 |
5 | HHV 6 | authKW | 391072 | 2% | 80% | 263 |
6 | CMV | authKW | 358596 | 3% | 44% | 434 |
7 | HCMV | authKW | 301182 | 1% | 69% | 235 |
8 | VALGANCICLOVIR | authKW | 283336 | 1% | 80% | 190 |
9 | CYTOMEGALOVIRUS INFECTION | authKW | 240330 | 1% | 61% | 213 |
10 | CYTOMEGALOVIRUS RETINITIS | authKW | 234337 | 1% | 83% | 151 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 204361 | 27% | 3% | 4424 |
2 | Transplantation | 47877 | 12% | 1% | 1889 |
3 | Immunology | 35345 | 23% | 1% | 3827 |
4 | Infectious Diseases | 25867 | 12% | 1% | 2036 |
5 | Microbiology | 14620 | 14% | 0% | 2235 |
6 | Ophthalmology | 6109 | 6% | 0% | 951 |
7 | Hematology | 4631 | 6% | 0% | 967 |
8 | Surgery | 2734 | 9% | 0% | 1491 |
9 | Pediatrics | 2366 | 5% | 0% | 843 |
10 | Biotechnology & Applied Microbiology | 1251 | 5% | 0% | 855 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VIROL | 81416 | 7% | 4% | 1215 |
2 | SERV VIROL | 51213 | 1% | 20% | 137 |
3 | SPERIMENTALI RIC | 33478 | 0% | 49% | 37 |
4 | MED VIROL EPIDEMIOL VIRAL DIS | 33042 | 0% | 48% | 37 |
5 | KLIN MOL VIROL | 27145 | 0% | 28% | 53 |
6 | INFECT DIS MICROBIOL TRANSLAT | 26451 | 0% | 30% | 47 |
7 | REFERENCE CYTOMEGALOVIRUS | 22459 | 0% | 93% | 13 |
8 | VACCINE GENE THER Y | 21361 | 0% | 17% | 67 |
9 | CLIN MOL VIROL | 20958 | 0% | 16% | 71 |
10 | AREA TR IANTOL | 18823 | 0% | 56% | 18 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF VIROLOGY | 70080 | 8% | 3% | 1233 |
2 | JOURNAL OF CLINICAL VIROLOGY | 57589 | 2% | 10% | 323 |
3 | JOURNAL OF MEDICAL VIROLOGY | 55493 | 3% | 6% | 479 |
4 | TRANSPLANT INFECTIOUS DISEASE | 29686 | 1% | 12% | 136 |
5 | JOURNAL OF INFECTIOUS DISEASES | 29482 | 3% | 3% | 535 |
6 | JOURNAL OF GENERAL VIROLOGY | 27063 | 3% | 3% | 446 |
7 | JOURNAL OF VIROLOGICAL METHODS | 16791 | 2% | 4% | 254 |
8 | TRANSPLANTATION | 15166 | 2% | 2% | 395 |
9 | TRANSPLANTATION PROCEEDINGS | 14590 | 4% | 1% | 577 |
10 | JOURNAL OF CLINICAL MICROBIOLOGY | 10789 | 2% | 2% | 403 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYTOMEGALOVIRUS | 2722225 | 15% | 59% | 2501 | Search CYTOMEGALOVIRUS | Search CYTOMEGALOVIRUS |
2 | HUMAN CYTOMEGALOVIRUS | 677134 | 3% | 69% | 525 | Search HUMAN+CYTOMEGALOVIRUS | Search HUMAN+CYTOMEGALOVIRUS |
3 | HUMAN HERPESVIRUS 6 | 446200 | 2% | 71% | 339 | Search HUMAN+HERPESVIRUS+6 | Search HUMAN+HERPESVIRUS+6 |
4 | GANCICLOVIR | 414202 | 3% | 48% | 464 | Search GANCICLOVIR | Search GANCICLOVIR |
5 | HHV 6 | 391072 | 2% | 80% | 263 | Search HHV+6 | Search HHV+6 |
6 | CMV | 358596 | 3% | 44% | 434 | Search CMV | Search CMV |
7 | HCMV | 301182 | 1% | 69% | 235 | Search HCMV | Search HCMV |
8 | VALGANCICLOVIR | 283336 | 1% | 80% | 190 | Search VALGANCICLOVIR | Search VALGANCICLOVIR |
9 | CYTOMEGALOVIRUS INFECTION | 240330 | 1% | 61% | 213 | Search CYTOMEGALOVIRUS+INFECTION | Search CYTOMEGALOVIRUS+INFECTION |
10 | CYTOMEGALOVIRUS RETINITIS | 234337 | 1% | 83% | 151 | Search CYTOMEGALOVIRUS+RETINITIS | Search CYTOMEGALOVIRUS+RETINITIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DE BOLLE, L , NAESENS, L , DE CLERCQ, E , (2005) UPDATE ON HUMAN HERPESVIRUS 6 BIOLOGY, CLINICAL FEATURES, AND THERAPY.CLINICAL MICROBIOLOGY REVIEWS. VOL. 18. ISSUE 1. P. 217 -+ | 377 | 89% | 214 |
2 | KOTTON, CN , KUMAR, D , CALIENDO, AM , ASBERG, A , CHOU, SW , DANZIGER-ISAKOV, L , HUMAR, A , (2013) UPDATED INTERNATIONAL CONSENSUS GUIDELINES ON THE MANAGEMENT OF CYTOMEGALOVIRUS IN SOLID-ORGAN TRANSPLANTATION.TRANSPLANTATION. VOL. 96. ISSUE 4. P. 333-360 | 197 | 82% | 174 |
3 | MANICKLAL, S , EMERY, VC , LAZZAROTTO, T , BOPPANA, SB , GUPTA, RK , (2013) THE "SILENT" GLOBAL BURDEN OF CONGENITAL CYTOMEGALOVIRUS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 26. ISSUE 1. P. 86-102 | 180 | 97% | 110 |
4 | BRITT, W , (2008) MANIFESTATIONS OF HUMAN CYTOMEGALOVIRUS INFECTION: PROPOSED MECHANISMS OF ACUTE AND CHRONIC DISEASE.HUMAN CYTOMEGALOVIRUS. VOL. 325. ISSUE . P. 417-470 | 294 | 79% | 140 |
5 | SIA, IG , PATEL, R , (2000) NEW STRATEGIES FOR PREVENTION AND THERAPY OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID-ORGAN TRANSPLANT RECIPIENTS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 13. ISSUE 1. P. 83 -+ | 375 | 83% | 142 |
6 | TORRE-CISNEROS, J , AGUADO, JM , GASTON, JJ , ALMENAR, L , ALONSO, A , CANTISAN, S , CARRATALA, J , CERVERA, C , CORDERO, E , FARINAS, MC , ET AL (2016) MANAGEMENT OF CYTOMEGALOVIRUS INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS: SET/GESITRA-SEIMC/REIPI RECOMMENDATIONS.TRANSPLANTATION REVIEWS. VOL. 30. ISSUE 3. P. 119 -143 | 241 | 85% | 1 |
7 | DOMINGUEZ, G , PELLETT, PE , BRAUN, DK , (1997) HUMAN HERPESVIRUS 6.CLINICAL MICROBIOLOGY REVIEWS. VOL. 10. ISSUE 3. P. 521 -+ | 336 | 77% | 225 |
8 | LURAIN, NS , CHOU, SW , (2010) ANTIVIRAL DRUG RESISTANCE OF HUMAN CYTOMEGALOVIRUS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 23. ISSUE 4. P. 689-712 | 182 | 90% | 153 |
9 | CROUGH, T , KHANNA, R , (2009) IMMUNOBIOLOGY OF HUMAN CYTOMEGALOVIRUS: FROM BENCH TO BEDSIDE.CLINICAL MICROBIOLOGY REVIEWS. VOL. 22. ISSUE 1. P. 76-+ | 208 | 75% | 215 |
10 | AGUT, H , BONNAFOUS, P , GAUTHERET-DEJEAN, A , (2015) LABORATORY AND CLINICAL ASPECTS OF HUMAN HERPESVIRUS 6 INFECTIONS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 28. ISSUE 2. P. 313 -335 | 167 | 91% | 17 |
Classes with closest relation at Level 2 |